Advertisement
Screener

Q/C Technologies, Inc. (QCLS) Deferred Revenue, Revenue Recognized

1.2 / 5 stars · 16/66 Roast Me

Q/C Technologies, Inc. Deferred Revenue, Revenue Recognized

Q/C Technologies, Inc. (QCLS) reported Deferred Revenue, Revenue Recognized of $26.26 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.

Discontinued › Income Statement › Other Income

us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2018-11-14

  • Q/C Technologies, Inc. deferred revenue, revenue recognized for the quarter ending 2018-09-30 was $26.26K, a 49.29% decline year-over-year.
  • Q/C Technologies, Inc. deferred revenue, revenue recognized for the quarter ending 2018-06-30 was $6.35K, a 90.64% decline year-over-year.
  • Q/C Technologies, Inc. deferred revenue, revenue recognized for the quarter ending 2018-03-31 was $57.73K, a 104.68% increase year-over-year.
  • Q/C Technologies, Inc. deferred revenue, revenue recognized for the quarter ending 2017-09-30 was $51.79K, a 38.44% decline year-over-year.
  • Q/C Technologies, Inc. deferred revenue, revenue recognized for fiscal 2017 was $126.47K.
  • Q/C Technologies, Inc. deferred revenue, revenue recognized for fiscal 2015 was $233.54K.
Period endDeferred Revenue, Revenue Recognized 3 monthDeferred Revenue, Revenue Recognized 3 month as first filedDeferred Revenue, Revenue Recognized 6 monthDeferred Revenue, Revenue Recognized 6 month as first filedDeferred Revenue, Revenue Recognized 9 monthDeferred Revenue, Revenue Recognized 9 month as first filedDeferred Revenue, Revenue Recognized 12 month
2018-09-30$26.26K
10-Q · filed 2018-11-14
$70.16K
10-Q · filed 2018-11-14
2018-06-30$6.35K
10-Q · filed 2018-08-14
$43.89K
10-Q · filed 2018-08-14
2018-03-31$57.73K
10-Q · filed 2018-07-13
2017-12-31$126.47K
10-K/A · filed 2018-07-13
2017-09-30$51.79K
10-Q · filed 2018-11-14
$224.47K
10-Q · filed 2018-11-14
$27.07K
10-Q · filed 2017-11-14
2017-06-30$67.86K
10-Q · filed 2018-08-14
$170.68K
10-Q · filed 2018-08-14
$24.29K
10-Q · filed 2017-08-14
2017-03-31$28.20K
10-Q · filed 2017-05-15
2016-12-31$41.12K
10-Q/A · filed 2018-07-13
2016-09-30$84.13K
10-Q · filed 2016-11-14
$299.78K
10-Q · filed 2016-11-14
2016-06-30$115.69K
10-Q · filed 2016-08-11
$215.65K
10-Q · filed 2016-08-11
2016-03-31$172.78K
10-Q · filed 2017-05-15
$99.97K
10-Q · filed 2016-05-12
2015-12-31$233.54K
10-K · filed 2017-04-11
2015-09-30$70.28K
10-Q · filed 2016-11-14
$362.15K
10-Q · filed 2016-11-14
2015-06-30$291.87K
10-Q · filed 2016-08-11
$291.87K
10-Q · filed 2016-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
BIOMERICA INC (BMRA)United States$0.011B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92